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A B S T R A C T
Background: Cyclists with flow limitations in the iliac arteries complain of pain and loss of power. To investigate
whether pedal power measurement has added value in diagnosing the underlying cause of flow limitations in the
iliac arteries, we explored the sensitivity and specificity of various pedal power measurement variables.
Moreover, it was assessed what the added value of pedal power measurement is compared to diagnosis based on
the conventional ankle-brachial blood pressure index.
Methods: 25 healthy participants and 45 patients with unilateral arterial flow limitations were recruited.
Participants received Echo-Doppler examination to determine the condition of the iliac arteries. Subsequently,
participants performed a maximal cycle ergometer test. During the cycling test the exerted left and right pedal
power was measured. From these measurements several variables were derived to diagnose arterial flow lim-
itations. A receiver operating characteristics curve based on a predicted cross-validated model was used to select
the variable with the highest predictive value and its cut-off value.
Findings: The mean power difference between both legs relative to the exerted power at 95% of the maximal
power showed the best predictive value with a sensitivity of 0.76 and a specificity of 0.88. Combining the pedal
power measurement and ankle-brachial blood pressure index resulted in a sensitivity of 0.91 and a specificity of
0.88.
Interpretation: Pedal power measurement improves sensitivity of diagnosis of iliac artery flow limitations,
without increasing the burden of clinical investigation to the patients.
1. Introduction
Up to 20% of professional cyclists develop a sports-related flow-
limitation in the iliac arteries (Schep et al., 2002c). Typical symptoms
are exercise-induced leg-pain and loss of power at near-maximal ex-
ercise; the pain disappears within a few minutes after ceasing exercise
(INSITE-Collaborators, 2016). It has been documented that not ather-
osclerosis but endofibrosis (thickening of the vessel intima), kinking of
the iliac arteries or a combination or both underlie such flow limitations
(Chevalier et al., 1986; Feugier and Chevalier, 2004; Schep et al.,
2002a). Especially at an early stage, endofibrosis and iliac kinking are
often not recognised, since current diagnostic tests lack sensitivity. It is
of clinical importance to detect these vascular problems at an early
stage, since at early stages conservative treatment or less invasive
surgery may be sufficient.
Iliac artery kinking is suggested to stimulate endofibrosis; the latter
may lead to arterial stenosis (Smith et al., 2008). Due to higher peak
systolic velocities the hemodynamic stress in the vessel is increased, this
may lead to intravascular damage resulting in endofibrosis (Schep
et al., 2001a). A factor associated with the development of the iliac
artery deformity is hip hyperflexion. To achieve an aerodynamic posi-
tion, hyperflexion occurs frequently in sports like cycling and ice speed
skating (Peach et al., 2012). The iliac artery runs in front of the hip joint
and during hip flexion its length becomes redundant. This is solved by
either elastic recoil or by an increase of tortuosity (bending or kinking
of the vessel). Especially, if there is kinking, this repetitive deformation
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of the iliac arteries may stimulate endofibrotic changes (Bender et al.,
2004). In some cases, the artery has been lengthened; this elongation of
the artery makes the vessel more tortuous and increases the likelihood
of kinking during hip flexion (Schep et al., 2002b).
To diagnose the iliac artery flow limitation a combination of tools is
available, such as patient's history, physical examination, ultrasound
examination, Ankle Brachial Index (ABI) of blood pressure after ceasing
a maximal exercise on a cycling ergometer and Magnetic Resonance
Angiography (MRA) (Bender et al., 2004). The best single test is ABI,
assessed immediately following a maximal exercise cycling test. This
test has a sensitivity of 73% for unilateral patients, while for bilateral
patients the sensitivity is only 43% (Abraham et al., 2001; Schep et al.,
2002c). Consequently, early diagnosis of arterial kinking is difficult
(Schep et al., 2001b).
A major complaint of cyclists with flow limitations is of loss of
power in the affected leg. Therefore, pedal power measurement (PPM)
may provide additional diagnostic value. It is assumed that healthy
participants distribute the power equally between both legs in-
dependent of the total power generated. For patients with unilateral
arterial flow limitations, it is expected that the power generated by the
affected leg will not increase proportional at exercise intensities that
demand more blood flow than can be supplied by the affected arteries.
The healthy leg might compensate and give extra power. Therefore,
variables that quantify the power difference between both legs at dif-
ferent intensities may provide added diagnostic value.
The purpose of this study was to investigate whether PPM is a useful
method to diagnose patients with unilateral flow limitations. Therefore,
we explored which PPM-variable is the most sensitive and specific for
diagnosis of iliac flow limitations. Finally, the added diagnostic value of
the best PPM-variable to ABI measurement has been assessed.
2. Methods
2.1. Participants
25 healthy and 45 patients (34 males and 11 females) participated
in measurements to explore which variable was the most sensitive and
specific indicator of iliac flow limitations and how much this variable
added to the diagnostic value.
The following inclusion criteria were used: generally healthy; aged
18–65 years, trained cyclists for> 5 years and on average> 5 h a
week. Participants were excluded if they were suffering from pul-
monary or cardiovascular disease or from a (neuro-) musculoskeletal
problem that interacted with cycling. The local Medical Ethics
Committee of Máxima Medical Centre, Veldhoven, The Netherlands
approved the study. The study was conducted in accordance with the
declaration of Helsinki.
2.2. Vascular diagnosis
Patients were recruited from a cohort of 372 patients that were
examined with complaints suspect for iliac artery flow limitations in the
period from January 30th 2013 till May 10th 2017 with flow limita-
tions in the iliac artery. The diagnostic work-up in these patients con-
sisted of patient history, physical examination and a standardised
maximal exercise test and echo Doppler examination as described in
more detail previously (Schep et al., 2001a; Schep et al., 2002c).
For our study only patients with definite documented flow limita-
tion in the iliac arteries on echo-Doppler in one leg and no abnormality
in the other leg were selected (Schep et al., 2001a; Schep et al., 2002c).
Also patients with concomitating serious other underlying causes for
complaints e.g. lumbar disc herniation were to be excluded. From 372
patients that were examined 144 patients had other underlying causes
for their complaints. Another 139 patients had bilateral complaints. Of
the other 89 vascular patients with unilateral complaints we still found
in 44 patients abnormalities in both legs on echo-Doppler (endofibrosis,
kinking and/or increased peak systolic velocities following criteria
described in (Schep et al., 2002a; Schep et al., 2002c)) which was
reason for exclusion.
Healthy participants were recruited from local cycling associations
and were also screened for flow limitations in the iliac artery with echo
Doppler and excluded if abnormalities were present. All examinations
were performed and scored by medical sports doctor G. Schep who is
experienced on diagnosing arterial flow limitations in the iliac arteries
(Schep et al., 2001a; Schep et al., 2002c).
2.3. Maximal exercise test
Each participant performed a provocative, maximal ramp cycle tests
on an electromagnetically braked cycle ergometer (Excalibur, a model
with Pedal Power measurement through strain gauges bonded on each
crank (925909), Lode, Groningen, the Netherlands). Participants were
clipped into pedals of their own preference. The ergometer constantly
corrected the instantaneous load to the actual pedal frequency to ensure
that the actual load matched the set ergometer load. To provoke leg
complaints, the test was performed in competitive posture with the
trunk in an almost horizontal position. All participants were instructed
to maintain this position during the entire maximal exercise test.
The exercise protocol consisted of a warm-up period followed by an
individualized, linear, maximal ramp protocol, which led to exhaustion
in 8 to 12min (O'Connor, 2013). The warm-up period had a duration of
4min at a workload of 10% of the estimated maximal workload based
on gender, mass, and training status. Because we wanted to offer a
familiar cycling experience, participants were instructed to keep a
constant pedal frequency of their preference as long as it was above
80 rpm. When participants were exhausted or reached a pedal fre-
quency below 70 rpm the test was terminated.
2.4. Blood pressure measurements
After ceasing the maximal exercise test, participants were instructed
to immediately detach from the pedals and to place their feet on a
resting platform, which was placed at the area of the pedals over the
bike. Participants had to remain seated in a competitive posture, while
five subsequent blood pressure measurements simultaneously on the
arm (Critikon 1846-SX, Soma Technology, Highland park Dr.
Bloomfield, USA) and ankles (Duo, Datascope Corp., Mahwah, USA)
were performed (O'Connor, 2013; Schep et al., 2002a). The first suc-
cessful simultaneous blood pressure measurement was used for ABI
analysis. The systolic blood pressure in the ankle was corrected for the
height difference with the arm (1 cm height difference= 0.76mmHg).
The ABI was calculated using the following formula:
ABI
systolic ankle blood pressure affected leg (0.76 height difference)
systolic brachial blood pressure
= ×
As a cut-off value for diagnosing arterial flow limitations, ABI of
0.54 was used (Schep et al., 2002a).
2.5. Pedal power measurements
The ergometer had a built-in pedal power technology, the pedal
power measurement was based on the distortion of strain gauges im-
plemented inside the crank. The software provided by the manufacturer
(Lode Ergometer Manager 10) translated the distortion of the strain
gauges to the torque (τ (Nm)) exerted on both pedals independently.
Based on the cadence (c), measured as revolutions per minute
(rpm), angular speed was calculated (ω=2π ∗ c / 60 (rad/s)).
Subsequently, the power (P (W)) was calculated by multiplying angular
speed and torque measured: P= τ ∗ω.
J.P.D. Kleinloog et al. Clinical Biomechanics 61 (2019) 211–216
212
2.6. Data analysis
First, outliers (e.g. unwanted body movements such as standing)
were detected using a Hampel filter. If the outlier exceeds three stan-
dard deviations from the median of itself and three neighbouring data
points of the median value, it is replaced with the median (Pearson,
2002). Thereafter, the data was filtered using a moving average filter
with a window of 11 data points.
The maximal power was determined when participants showed a
5% decrease of the median pedal frequency. The analyzed data ranged
from the moment after the warm-up (0%) period until maximal power
was reached (100%).
The power exerted by both legs together equals the ergometer load.
In an ideal situation, in healthy individuals the power exerted by both
legs would be almost equal. In patients with functional vascular pro-
blems, kinking, endofibrosis or a combination of both limits the blood
supply in the affected leg. Consequently, especially at high effort the
blood supply towards the affected leg is unable to meet the oxygen and
substrate demands. Due to this it is expected that the muscles in the
affected leg will be unable to produce the same power as those in the
healthy leg (Joyner and Casey, 2015). As a result, it is to expect that the
power difference between healthy and affected leg will increase with
increasing load. Therefore, the power difference between both legs at
95% and 99% of the maximal (100%) exerted power was selected to
test the potential most discriminating variable (Fig. 1A). Additionally,
we hypothesized that power differences between both legs at sub-
maximal exercise intensities could be present, due to individual dif-
ferences like a stronger preference leg. These differences should be
visible in healthy persons throughout the complete test and in patients
only at submaximal exercise intensities when there is still no dis-
crepancy between blood supply and blood demand. In an additional
analysis, the variable with the highest sensitivity and specificity at
maximal intensity with the power difference at submaximal exercise
intensity (25%) was therefore corrected.
For each pedal cycle, the mean and the maximal power was calcu-
lated. To compensate for inter-cycle variability, the maximal and mean
power were averaged over 10 pedal cycles. This resulted in the mean
and maximal power difference between both legs averaged over 10
pedal cycles at 95% and 99% of the maximal generated power at the
maximal exertion test. To compensate for inter-individual differences in
maximal exerted power, the power difference between both legs for the
maximally generated mean power was normalized. This was calculated
using the following formula:
normalized power Power difference between both legs
Maximal generated power
100= ×
Variables were checked for normal distribution using a graphical
method (histogram) and Shapiro-Wilk tests. For statistical significance,
alpha was set at 0.05. Anthropometrics from healthy participants and
participants were tested for significant differences using an in-
dependent t-test. The mean and maximal pedal power exerted with the
left and right leg for healthy participants and affected and unaffected
leg for patients was tested for significant difference using a paired t-test.
Receiver operating characteristic (ROC) curves were generated to de-
termine the variable that performed best on predicting patients with
arterial flow limitations. The ROC curves compare sensitivity versus
specificity across a range of cut-off values for the ability to predict a
dichotomous outcome (Florkowski, 2008). The sensitivity
( )True PositiveCondition Positive is defined as the proportion of positives that are cor-
rectly identified, while the specificity ( )True NegativeCondition negative is defined as the
proportion of negatives that are correctly identified. Thereafter, the
optimal cut-off point was determined using the Youden Index, which
defines the maximum potential effectiveness of a biomarker (Hajian-
Tilaki, 2013). The Youden Index optimizes the biomarker's differ-
entiating ability when equal weight is given to sensitivity and
specificity. If for example, preference would be given to specificity, this
would have a disadvantageous effect on the sensitivity. Using the R
caret function a 10-fold cross-validation with 100 repeats was per-
formed to increase the precision of the sensitivity and specificity esti-
mates while still maintaining a small bias, since the model is based and
validated on the same participant group. The cross-validation model
was trained using a generalised linear model. The used predictive
modelling process is described in more detail by the authors of the R
caret function (Kuhn and Johnson, 2013).
Finally, the diagnostic value of the ABI using the previously re-
ported cut-off value of 0.54 was determined (Schep et al., 2002a). Also,
the predictive and corresponding cut-off values were determined using
the previously described cross-validation method. Additionally, the
added value of PPM was determined by investigating the predictive
value of a combination of the PPM and ABI. If the predicted population
met either the PPM or the ABI criteria, they were classified as patient
with flow limitations in the iliac arteries.
3. Results
3.1. Participants
Age, length, weight, BMI and distance cycled during lifetime did not
significantly differ between the healthy participants and patients for the
sensitivity and specificity analysis (Table 1). The maximal workload
(Pmax), maximal workload per kilogram body weight (Pmax/weight) and
ABI for the affected side as well as the non-affected side differed sig-
nificantly between healthy participants and patients (Table 1). The
patient group that was used for the sensitivity and specificity analysis
had primarily vascular problems located in the external iliac artery (26
participants). Besides, unilateral vascular problems were predominant
on the left side (33 participants) (Table 1). All data were normally
distributed.
3.2. Pedal power
Typically, the pedal power generated by the left and the right leg
increased linearly with ergometer load (Fig. 1A). In patients, the power
increase of the affected leg declined above a specific ergometer load
(Fig. 1A and B). Over one pedal cycle, the power generated by either
the right or left leg showed a sinusoidal pattern (Fig. 1B).
3.3. Diagnostic values
There was no significant difference between the affected and un-
affected leg at the mean and maximal power exerted at 95% and 99% in
healthy participants. In patients with arterial flow limitations the mean
and maximal power exerted at 95% and 99% were significantly lower
in the affected leg compared to the unaffected leg (Table 2).
The mean power difference between both legs at 95% of the max-
imal reached power (Fig. 2) had a sensitivity of 0.76, the specificity was
0.88 using 5.10 as cut-off value. The mean power difference between
both legs at 99% of the maximal power showed a sensitivity of 0.66 at a
specificity of 0.92 using a cut-off value of 4.73. The maximal power
difference between both legs at 95% had a sensitivity of 0.60 with a
specificity of 0.88 using a cut-off value of 17.22. The maximal power
difference between both legs at 99% showed a sensitivity of 0.71 and a
specificity of 0.76 using a cut-off value of 19.27. The sensitivity of the
ratio of the mean power difference between both legs at 95% and 25%
was 0.56 with a specificity of 0.80, using a cut-off value of 0.40.
3.4. Comparison PPM and ABI
For the healthy participants mean corrected ABI was 0.94 (SD 0.13),
the mean corrected ABI for the affected leg in patients was 0.63 (SD
0.16). Using previously reported cut-off value of 0.54, this resulted in a
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sensitivity of 0.76 and a specificity of 1. Performing the ROC-curve
analysis on the cross validated predicted model results in a sensitivity of
0.78 while maintain a specificity of 1 using a cut-off value of 0.67. For
further analysis we worked with a cut-off value of 0.54, to make the
results comparable with previous reports. The mean power difference
between both legs at 95% combined with the ABI using the current
study population resulted in a sensitivity of 0.91 and a specificity
of 0.88.
4. Discussion
This study was designed to explore whether PPM had an added
value for diagnosing iliac artery flow limitations and to explore which
PPM-variable was most sensitive and specific, and to compare the
predictive power of this variable to the conventional ABI-test. The
variable with the best predictive value was the mean power difference
relative to the exerted power at 95% of the maximal power (sensitivity
0.76; specificity 0.88) with a cut-off value of 5.10.
Combining this PPM variable with ABI shows an increase in sensi-
tivity from 0.76 to 0.91, the specificity decreases from 1.00 to 0.88.
Meaning that an additional 13% patients with flow limitations were
correctly identified, while approximately 7% healthy participants
would have been wrongly identified as having flow limitations.
Accordingly, both methods measure different effects of functional ar-
terial flow limitations. Therefore, PPM can be effectively used com-
plementary to ABI and to quantify both flow limitation and loss of
power.
While determining the diagnostic values the power difference be-
tween both legs decreased at a maximal intensity (99%), which may be
due to fatigue of the healthy leg resulting in a power increase of the
Fig. 1. Typical power pattern with increasing ergometer load of a healthy participant (A) and of a unilateral vascular patient (B). Typical power pattern over one
pedalling cycle of a healthy participant (C) and of a unilateral vascular patient (D). Fig. A and B show the measured Pedal Power and the increasing power difference
between both legs with increasing ergometer load for a unilateral vascular patient, while fore the healthy subject the power exerted by both legs is almost equal. The
vertical dotted lines show the start (0%) and the end (100%) of the maximal cycling test; the solid vertical lines show 25%, 50%, 95% and 99% of the maximal cycling
test. B) Shows the power measured during one pedal cycle for both legs independently. The horizontal dotted lines represent the mean and maximal variables for both
legs as used for data analysis.
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affected leg. Besides, at near maximal exercise participants had the
tendency to decrease their rpm faster than the ergometer can correct
for. Since the ergometer load is dependent on cadence, this resulted in a
decrease in the exerted power. Furthermore, the participants tended to
compensate by adopting different cycling techniques and positions. The
shift in power distribution between both legs in relation to the decrease
in cadence at near maximal exercise may explain the highest diagnostic
value of 95% instead of 99% of the maximal exerted power.
To correct for power differences present at submaximal intensities,
the mean power difference at 95% relative to the power difference at
submaximal exercise intensity (25%) was used. This variable was pro-
posed, because at low intensities there is still a balance between de-
mand for blood flow and actual blood flow. Especially at the higher
intensities we expect that the flow of blood is less than is required by
the working muscle in the affected leg. Also, several individual patients
showed an opposite power difference between both legs at submaximal
intensities compared to maximal intensities. We believed that that
correcting for this baseline might increase the sensitive and/or speci-
ficity value. However, this study showed that on group level this was
not the case.
To our knowledge, this is the first study examining PPM as a diag-
nostic tool for arterial flow limitations. The idea of using PPM origi-
nates from the fact that the main complaint of cyclists with flow lim-
itations consists of a loss of power in the affected leg with increasing
exercise intensity. PPM is an easily available measurement tool on an
ergometer and since a maximal cycling test is already being performed
for determining ABI to diagnose arterial flow limitations no extra effort
is necessary. Therefore, including this variable in the current diagnostic
algorithm requires no additional discomfort for the patient, while
adding diagnostic value. Also, PPM is currently increasingly applied
during cycling practice and there are systems on the market that pre-
tend to measure pedal power in both legs independently. Our study
indicates that power differences at near maximal intensity may be an
indicator for an underlying flow limitation.
Limitations to apply pedal power measurements in the diagnosis of
flow limitations arise in patients with bilateral flow limitation and both
sided complaints. However, also in these patients, information on pedal
power may help to determine which leg is most affected and has the
highest power deficit. In our experience, this is sometimes not the leg
that the patient identifies, which underlines the clinical importance for
objective measurement. Pedal power measurement may than help in
guiding treatment since it gives more objective information on which
leg is most affected and may benefit most from operation. Another
limitation of this study is the generalisability to a more heterogeneous
population, since the studied population did not suffer from other
complaints except for arterial flow limitations. This would be an im-
portant next step in validating PPM as diagnostic tool. Additionally, to
increase the precision of the prediction we used a cross-validation
Table 1
Anthropometric measurements of the included participants for both the sensi-
tivity and specificity study and the reliability analysis.
Healthy participants
(n= 25)
Patients (n= 45)
Age (years) 33.6 (SD 12.9) 39.9 (SD 14.3)
Length (cm) 182 (SD 6) 180 (SD 8)
Weight (kg) 71.9 (SD 6.5) 76.4 (SD 20.6)
BMI (kg/m2) 21.7 (SD 1.6) 23.4 (SD 5.4)
Sport 25 cyclists 32 cyclists
6 ice skaters
4 triathletes
2 runners
1 rower
Competitive level 0 professional
20 national
5 recreational
6 professional
19 competitive
20 recreational
Cycled in lifetime (km) 186,915 (SD 155655) 152,365 (SD 129296)
Pmax (W) 438 (SD 50) 358 (SD 90)˟
Pmax/weight (W/kg) 6.12 (SD 0.74) 4.93 (SD 1.58)˟
ABI left/affected sidea 0.76 (SD 0.13) 0.41 (SD 0.17)˟
ABI right/non-affected
sidea
0.81 (SD 0.13) 0.57 (SD 12)˟
Side of vascular problem None 33 left
12 right
0 bilateral
Type of vascular problem – 8 kinking
18 endofibrosis
19 both
Location of vascular
problem
– 26 external iliac a.
9 common iliac a.
10 both
a For healthy participants left or right side. For unilateral vascular patients
the ABI is reported as the affected and non-affected side. For bilateral vascular
patients the ABI is reported as the most-affected and least-affected side.
˟ Significant different from healthy participants (P < 0.001).
Table 2
Pedal power exerted on the left and right side for healthy participants and on the affected and unaffected side for patient.
Healthy participants Patients
Left Right P-value Affected Unaffected P-value
Mean power 95% (W) 208 (SD 30) 209 (SD 29) 0.914 150 (SD 48) 179 (SD 48) <0.001
Mean power 99% (W) 215 (SD 28) 215 (SD 30) 0.951 156 (SD 47) 185 (SD 46) <0.001
Maximal power 95% (W) 816 (SD 126) 810 (SD 12) 0.730 618 (SD 141) 694 (SD 134) <0.001
Maximal power 99% (W) 816 (SD 126) 819 (SD 12) 0.889 623 (SD 137) 708 (SD 125) <0.001
Fig. 2. Receiver operating characteristic (ROC)-curve of the mean and maximal
power difference between both legs during the pedal revolution averaged over
ten cycles relative to the exerted power at 95% and 99% of the maximal ex-
ercise test. Also, the ratio of the mean power difference between both legs at
95% between 25% of the maximal test is shown within the ROC-curve. The
square dots on the lines correspond to the optimal cut-off point based on the
Youden-method.
J.P.D. Kleinloog et al. Clinical Biomechanics 61 (2019) 211–216
215
model which was the best option given the current data (Kuhn and
Johnson, 2013). However, PPM to diagnose arterial flow limitations
should also be validated on another different population.
This study focused on the power exerted over the whole testing
range. Further research may focus on the reproducibility of the pro-
posed pedal power variable. Besides, flow limitations in the iliac ar-
teries may result in different muscle activation patterns during the
pedal revolution based on the blood vessel anatomy. Therefore, in-
formation on pedal power pattern changes during the pedal cycled
could provide additional diagnostic information (Hug and Dorel, 2009).
Additionally, pedal power measurement is increasingly used in the
field, misbalance between the exerted power between legs combined
with typical complaints could provide an early indication of flow lim-
itations in the iliac arteries. The current study already provides a better
understanding of the (pathologic) patterns that can be expected. Also,
in patients treated for flow limitations power measurement may pro-
vide more objective data on the effectiveness of treatments and may
guide rehabilitation/training to competitive level.
5. Conclusion
PPM is a useful additional tool for the current algorithm to diagnose
flow limitations in the iliac arteries in athletes, without being an extra
burden for the patient. The mean power difference between both legs
relative to the power exerted at 95% of the maximal achieved power is
the most discriminating variable with 5.10 as the cut-off value. Further
research may optimize the application of PPM as a diagnostic tool.
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